about
CT-P13 in the treatment of rheumatoid arthritis.Biosimilars for psoriasis: clinical studies to determine similarity.Rheumatologists' Perceptions of Biosimilar Medicines Prescription: Findings from a French Web-Based Survey.Identification of multiple serine to asparagine sequence variation sites in an intended copy product of LUCENTIS® by mass spectrometry.Knowledge, behaviors and practices of community and hospital pharmacists towards biosimilar medicines: Results of a French web-based survey.ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update.Unmet Needs in the Field of Psoriasis: Pathogenesis and Treatment.Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers.
P2860
Q38676104-C90264F7-8A29-4024-AA08-2A568006E3D0Q38957406-8668426D-EA19-4CF9-AD58-90671F6176BAQ39184810-81323DD2-C62F-47E4-AF60-5EC0AC94632AQ50328050-D95CC4AA-0DB8-4AFB-BA44-FE97E4DC9738Q51022840-5208DD35-2C42-469D-B66E-933830E81F5DQ51280643-54260953-7CCF-41FF-BAE1-46F547400ADFQ53123754-5BE83450-3684-4E1C-BBC2-AB6313518280Q54135887-04E7C007-CAC5-4A79-B6D1-61EF1EEEDDB0
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Biosimilar regulation in the EU.
@en
type
label
Biosimilar regulation in the EU.
@en
prefLabel
Biosimilar regulation in the EU.
@en
P2860
P1476
Biosimilar regulation in the EU.
@en
P2093
Niklas Ekman
Pekka Kurki
P2860
P304
P356
10.1586/17512433.2015.1071188
P407
P577
2015-09-01T00:00:00Z